The study demonstrates dynamic changes in alpha-melanotrophin levels in the human fetal pituitary gland throughout gestation, suggesting a role for pars intermedia peptides in fetal development.
Answers are grounded in this paper and cite their sources.
No immediate clinical relevance; leaves open the developmental role of fetal pituitary alpha-melanotrophin.
alpha-Melanotrophin was detected by radioimmunoassay in the human fetal pituitary gland from 11 weeks of gestation. The peak hormone concentration of 3.4 nmol/g pituitary tissue was reached at 17-20 weeks. From 17 to 36 weeks of gestation the total gland content rose gradually from 28 to 102 pmol. During this latter period, the pituitary gland grew some 10-fold, with the result that the alpha-melanotrophin concentration declined steadily to 1.3 nmol/g. In the final month of gestation, both the total gland content and the concentration of alpha-melanotrophin rose significantly to 254 pmol and 2.4 nmol/g respectively. The variations in pituitary gland content of alpha-melanotrophin were consistent with a role for pars intermedia peptides in the fetus. alpha-Melanotrophin-like peptides were not demonstrated in human placental tissue.
No takes yet. Share an insight, caveat, or question.
John F. Wilson (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: